Medical University of South Carolina Every person living with type 1 diabetes (T1D)  knows the daily routine: checking blood sugar, calculating carbs, dosing insulin — day in and day out. But what if scientists could stop the disease at its source  instead of just managing it? That’s exactly what a new research initiative funded with a $1 million grant  from an organization called "Breakthrough T1D" is trying to do: reprogram the immune system so it stops attacking insulin-producing cells in...

A promising new development could change how doctors approach type 1 diabetes (T1D)  in young children. The U.S. Food and Drug Administration  is reviewing an expanded use of a drug called Tzield (teplizumab)  that may delay the onset of clinical type 1 diabetes  in children as young as 1 year old . If approved, this would be the first treatment designed to slow the progression of type 1 diabetes before symptoms appear  in very young children. What Is Tzield (Teplizumab)? Tzield is an...

The American Diabetes Association (ADA)  has released its highly anticipated Standards of Care in Diabetes—2026 , a comprehensive update to the gold standard guidelines clinicians and health systems rely on for diagnosing, treating, and managing diabetes and prediabetes in people of all ages. These new standards reflect the latest scientific evidence and are designed to improve health outcomes and quality of care for millions of people living with diabetes. ( American Diabetes Association )...